Comments
Loading...

Lexeo Therapeutics

LXEONASDAQ
Logo brought to you by Benzinga Data
$7.62
0.273.67%
Pre-Market: 7:13 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$28.00
Lowest Price Target1
$19.00
Consensus Price Target1
$22.71

Lexeo Therapeutics (NASDAQ:LXEO) Stock, Analyst Ratings, Price Targets, Forecasts

Lexeo Therapeutics Inc has a consensus price target of $22.71 based on the ratings of 7 analysts. The high is $28 issued by Baird on June 13, 2024. The low is $19 issued by Leerink Partners on November 13, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Chardan Capital, and Leerink Partners on November 14, 2024, November 13, 2024, and November 13, 2024, respectively. With an average price target of $22.33 between HC Wainwright & Co., Chardan Capital, and Leerink Partners, there's an implied 193.09% upside for Lexeo Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Jun
2
Jul
3
Aug
3
Oct
3
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Chardan Capital
Leerink Partners
RBC Capital
Baird

1calculated from analyst ratings

Analyst Ratings for Lexeo Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Lexeo Therapeutics (LXEO) stock?

A

The latest price target for Lexeo Therapeutics (NASDAQ:LXEO) was reported by HC Wainwright & Co. on November 14, 2024. The analyst firm set a price target for $23.00 expecting LXEO to rise to within 12 months (a possible 201.84% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Lexeo Therapeutics (LXEO)?

A

The latest analyst rating for Lexeo Therapeutics (NASDAQ:LXEO) was provided by HC Wainwright & Co., and Lexeo Therapeutics maintained their buy rating.

Q

When was the last upgrade for Lexeo Therapeutics (LXEO)?

A

There is no last upgrade for Lexeo Therapeutics

Q

When was the last downgrade for Lexeo Therapeutics (LXEO)?

A

There is no last downgrade for Lexeo Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Lexeo Therapeutics (LXEO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lexeo Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lexeo Therapeutics was filed on November 14, 2024 so you should expect the next rating to be made available sometime around November 14, 2025.

Q

Is the Analyst Rating Lexeo Therapeutics (LXEO) correct?

A

While ratings are subjective and will change, the latest Lexeo Therapeutics (LXEO) rating was a maintained with a price target of $21.00 to $23.00. The current price Lexeo Therapeutics (LXEO) is trading at is $7.62, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch